期刊文献+

35例精神分裂症患者神经心理学评估的对照研究 被引量:10

A Control Study of Neuropsychological Function in 35 Schizophrenic Patients
下载PDF
导出
摘要 目的:用神经心理测验评估35例精神分裂症患者认知功能损害的特点。方法:采用多种神经心理测验评估35例精神分裂症患者(12例未用药,8例用药1周以内,15例用药1月以上)和20例健康对照组的学习、记忆、工作记忆、注意、信息处理速度、词语流畅、执行功能等认知功能。对未用药和用药1周以内的精神分裂症患者进行随访。结果:在成套神经心理测验的各个分测验中,精神分裂症患者(未用药、用药1周以内和用药1月以上)成绩均较正常人差[如韦氏数字符号得分未用药者(63.0±13.8),正常对照组(87.10±13.16),P<0.001]。用药1月以上组的空间广度测验成绩优于未用药组[逆行得分成绩用药1月以上组(7.47±1.81),未用药组(5.50±1.73),P<0.01;总分成绩用药1月以上组(15.33±3.31),未用药组(12.42±3.65)]。随访研究中,霍普金斯词汇学习测验-修订版、简易视觉空间记忆测验-修订版和视觉空间广度测验的随访成绩优于初测成绩[如空间广度测验的逆行得分初测成绩(5.7±1.5),随访成绩(6.8±1.0,P<0.05)]。结论:精神分裂症患者存在大脑广泛的认知功能损害。非经典抗精神病药物治疗可能对精神分裂症患者的言语记忆、视觉空间记忆和视觉工作记忆有所改善。 Objective: To evalnate the neurocognitive function in 35 schizophrenia patients by a series of standardized neuropsychologieal tests. Methods: Thirty-five schizophrenia patients including patients untreated ( n = 15), treated with anti-psychotics less than 1 week ( n = 8 ), or more than 1 month( n = 15 ) , 20 matched healthy controls were involved, and 12 patients including unmedicated ( n = 6) and medicated less than 1 week (n = 6) were followed up after 4 weeks. Patients and controls were evaluated by several neuropsychologieal tests designed to measure learning, memory, attention, information processing and executive function. Results: Healthy controls performed better than schizophrenia patients in the majority of cognitive tests ( P 〈 0. 05 ) . In the Spatial Span Test, patients who were medicated more than 1 month performed better than patients who were unmedicated ( P 〈 0. 051 An improvement was found at follow-up in both patient groups ( P 〈0. 05 ) in the Hopkins Verbal Learning Test-Revised ( HVLT-R), Brief Visuospatial Memory Test-revised ( BVMT-R ) and Spatial Span Test. Conclusion: The findings indicate that schizophrenia patients exhibit a wide range of impairments incluoling learrning, memory, working memory, attention/concen, tration, information processing, and executive function, Although autipsychotics have not significantly changes on the neurocognitive function in schizophrenia patients, the unmedicated patieuts'nenrocognitive function are wgrse, and the antipsyehotics might have some effects on verbal memory visual-spatial memory and visual working memory.
出处 《中国心理卫生杂志》 CSSCI CSCD 北大核心 2008年第10期713-716,728,共5页 Chinese Mental Health Journal
关键词 精神分裂症 正常人对照 神经心理学测验 认知功能 病例对照研究 schizophrenia cognitive function cognitive deficits neuropsyehology ease control study
  • 相关文献

参考文献13

  • 1Hoff AL. Neuropsychological function in schizophrenia. // Shriqui CL, Nasrallah HA, editors. Contemporary issues in the treatment of schizophrenia [M]. Washington, DC : American Psychiatric Press, 1995 : 187 - 208.
  • 2Saykin AJ, Gttr RC, Gur RE, et al. Neuropsychological function in schizophrenia: selective impairment in memory and learning [J] . Arch Gen Psychiatry , 1991, 48: 618 -624.
  • 3范肖东,汪向东,于欣,等.ICD-10精神与行为障碍分类(临床描述与诊断要点)[M].北京:人民卫生出版社,1993:9.
  • 4石川,于欣,吴尊友,Robert K.Heaton,JIN Hua,Thomas D.Marcotte,Joseph Sadek,Igor Grant.中国HIV+/AIDS患者神经心理学初步研究[J].中国心理卫生杂志,2005,19(5):343-346. 被引量:29
  • 5何燕玲 张明园.阳性与阴性症状量表(PANSS)及其应用.临床精神医学杂志,1998,7:353-353.
  • 6Morice R, Delahunty A. Frontal executive impairment in schizophrenia [J] . Seh Bull, 1996, 22: 125.
  • 7Gallhofer B, Bauer U, Lis S, et al. Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs [ J ] . Euro Neuropsychopharmacology, 1996, 6 (Supp 12) : 13 - 20.
  • 8Gold JM, Randolph C, Carpenter CJ, et al. Forms of memory failure in schizophrenia [ J ]. J Abnorm Psychol, 1992, 101 (3) : 487 -494.
  • 9Park S, Holzman PS. Schizophrenics show spatial memory deficits [J]. Arch Gen Psychiatry, 1992, 49:975 -982.
  • 10Rossi A, Daneluzzo E, Mattei P, et al. Wisconsin card sorting test and Stroop test performances in Schizophrenia: a shared construct [J]. Neurosci Letters, 1997, 226: 87-90.

二级参考文献10

  • 1Beck AT. Beck Depression Inventory: Manual. San Antonio,TX: The Psychological Corporation, 1993.
  • 2Heaton RK, Grant I, Butters N, et al. The HNRC 500-Neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1995,1(3):231-251.
  • 3AtkiusonJH, Grant I. Neuropsychiatry of human immunodeficiency virus infection. In: Berger JR & Levy RM (Edls). AIDSand the nervous system. 2nd ed. Philadelphia: Lippincott-Raven, 1997.419-449.
  • 4Rabkin JG: Prevalence of psychiatric disorders in HIV illness.Iht Rev Psychiatry 1996, 8(2-3): 157-166.
  • 5Dew MA, Ragni MV, Nimorwicz P. Infection with human immunodeficiency vims and vulnerability to psychiatry distress:A study of men with hemophilia. Arch Gen Psychiatry 1990,47(8): 737-744.
  • 6Goggin KJ, Zisook S, Heaton RK, et al. Neuropsychological performance of HIV-1 infected men with major depression. JIht Neuropsychol Soc 1997,3(5):457-464.
  • 7Hinkin CH, Van Gorp WG, Satz P, et al. Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. J Clin Exp Neuropsychol 1992,14(12): 289-297.
  • 8China Ministry of Health and the UN Theme Group on HIV/AIDS in China. A Joint Assessment of HIV/AIDS Prevention, Treatment, and Care in China. Beijing: State Council AIDS Working Committee Office, National Center for AIDS/STD Prevention and Control, Chin CDC, UNAIDS China Office, eds. 2004.7-18.
  • 9Ellis RI, Deutsch R, Heaton RK, et al. Neurocognitive impairment is an independent risk factor for death in HIV infection.San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 1997,54(4):416-424.
  • 10Heaton RK, Marcotte TD, Ellis RJ, et al. Neuropsychological profile and prognostic significance of Minor cognitive/Motor Disorder. J Neurovirol 1996,2:39.

共引文献41

同被引文献146

引证文献10

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部